Sign in
Not yet taking people in United StatesNo phase

The ConCERN Intervention for Loved Ones of Those With Opioid Use Disorder

Key facts

Who runs it
University of Michigan
Where
Ann Arbor and Detroit, United StatesSee the 2 sites
Trial code
Status
Not yet recruiting
People taking part
700 people, planned
Started
Sept 2026
Expected to end
Feb 2029
Type of study
Interventional, 2 groups
Treatments tested
  • ConCERN intervention
  • Treatment as Usual
Record updated
31 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Other criteria

  • CSOs (Randomized participants) Inclusion Criteria:
  • Identifies as a support person of a PWUO
  • Communicated with PWUO in the past 6 months; PWUO (Randomized participants) Inclusion Criteria:
  • Identifies as a PWUO
  • Has used opioids in the past 6 months
  • Can name a CSO and provide their contact information; CSOs (Randomized participants) Exclusion Criteria:
  • Can't read English
  • Doesn't have email and phone/tablet/computer access
  • Located outside of the U.S; PWUO (Randomized participants) Exclusion Criteria:
  • Can't read English
  • Doesn't have email access
  • Located outside of the U.S
  • CSOs they named they named doesn't enroll in study
  • Does not complete baseline survey within 30 days of CSO baseline survey completion date

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Katharine GrandinettiNot yet recruiting
  • Wayne State UniversityDetroit, United StatesContact: Taqwa KhalaffNot yet recruiting

About the trial

What the trial wants to find out

Evidence suggests that friends and family play an important role in supporting loved ones that are addicted to opioids. However, there are limited unique resources available for this population of friends and family. This study aims to develop a brief digital educational intervention for these support people called "ConCERN" with the hopes of reducing stigma, enhancing navigation of health and treatment systems, building positive communication skills, and improving well-being for both the loved ones and the people who use opioids.

The 2 groups in the trial

  • ConCERN interventionTreatment being tested
  • Treatment as Usual (TAU)Other group

    After the 1 and 3-month surveys are completed participants will be offered a unique link access to the ConCERN website.

    Treatment: Treatment as Usual

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Testing the ConCERN Intervention for Concerned Significant Others of Those With Opioid Use Disorder Through Randomized Controlled Trial
Record updated
31 August 2026